• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Abstract Background/Aims: Public understanding of the role of genetics in disease risk is key
to appropriate disease prevention and detection. This study assessed the current extent of …

A MESSAGE FROM ASCO'S PRESIDENT I am pleased to present Clinical Cancer
Advances 2017, which highlights the most promising advances in patient-oriented cancer …

Effective communication, where all parties share a common understanding, is necessary to
realize the promise of Genomic Medicine. It is especially salient given the imperative to …

As genomic and personalized medicine becomes mainstream, assessing and
understanding the public's genetic literacy is paramount. Because genetic research drives …

Advances in the application of genomic technologies in clinical care have the potential to
increase existing healthcare disparities. Studies have consistently shown that only a fraction …

Cancer-related genetic and genomic testing (CGT) is changing cancer care by personalizing
care options, leading to an era of precision medicine. Advances in and increased use of …

The use of genomic data in research and genomic information in clinical care is increasing
as technologies advance and sequencing costs decrease. Using Rogers' Diffusion of …

Background: The huge development of omics sciences is changing the classical medical
approach and making new technologies available. In this context, education of citizens is …

Genome‐wide association studies (GWAS) provide valuable information in research
contexts regarding genomic changes that contribute to risks for complex psychiatric …